Drawing for 6008 CARESYSTEM

USPTO serial 79397198

6008 CARESYSTEM

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
MCMORROW, JANICE LEE
Law office
TMO LAW OFFICE 115

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with 6008 CARESYSTEM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alison M. Caless

Alison M. Caless Cantor Colburn LLP20 Church Street22nd FloorHartford, CT 06103

Goods and services

ClassDescriptionStatusFirst use
010Surgical and medical apparatus and instruments all for the treatment of kidney failure and used in dialysis treatment.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 19, 2026MAB1ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT—
May 19, 2026ABN1ABANDONMENT - EXPRESS MAILED—
May 18, 2026EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Dec 18, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 18, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 18, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 2, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 2, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 2, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 22, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Nov 5, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 5, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 27, 2025RFNTREFUSAL PROCESSED BY IB—
Jun 3, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 3, 2025RFRRREFUSAL PROCESSED BY MPU—
Apr 22, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 21, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 2025DOCKASSIGNED TO EXAMINER—
Apr 18, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 18, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 10, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jun 10, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 10, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 10, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 10, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 6, 2024SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance